Clinical Research Advantage

CRA wins ViE award for best clinical trial site network

Wednesday, April 18, 2012 01:02 PM

Tempe, Ariz.-based Clinical Research Advantage (CRA), a community-based network of clinical trial sites, has been named best clinical trial site network bythe World Vaccine Congress.

More... »


Clinical Research Advantage adds clinical trials in rural Nebraska

Friday, March 2, 2012 01:39 PM

Tempe, Ariz.-based Clinical Research Advantage (CRA), a provider of research services to pharmaceutical companies and CROs, will begin offering patients throughout rural Nebraska the opportunity to participate in additional clinical trials.

More... »


Clinical Research Advantage named among az magazine’s ‘Top 25 Workplaces for Women’

Friday, February 10, 2012 11:50 AM

Clinical Research Advantage (CRA), a trial management organization based in Tempe, Ariz., has been selected among az magazine’s top 25 workplaces for women.

More... »

Clinical Research Advantage Expanding to Las Vegas, Omaha

Monday, April 12, 2010 07:12 AM

After 20 years of business, site management organization (SMO) Clinical Research Advantage (CRA) is expanding beyond its home base of Phoenix buying five sites in Las Vegas and plans to open a site in Omaha, Neb.

More... »


CWWeekly

May 21

Parexel consultant testifies on FDA biosimilars guidance

Global Telecom Testing checks worldwide toll-free phone lines for multinational clinical trials

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

May

Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…

Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…

Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs